Basic Information
BacterioScan has developed an innovative automated clinical microbiology testing platform that provides rapid detection of infections and antimicrobial susceptibility testing (AST). These in vitro diagnostic (IVD) products can guide effective treatment of infectious diseases in a world of increasing antibiotic resistance, reducing the time to results by more than 90% for most patients.
BacterioScan Inc.
United States of America
15~50 people
January 01, 2004
dmarshall.bscan@gmail.com

